Similar articles for PMID: 28933411

Year	Number of Results
2006	1
2007	3
2008	4
2009	2
2010	2
2011	1
2012	3
2013	6
2014	4
2015	8
2016	10
2017	9
2018	3
2019	8
2020	9
2021	14
2022	17
2023	9
2024	0

1

Mitochondrial Dysfunction in Lysosomal Storage Disorders.

de la Mata M, Cotán D, Villanueva-Paz M, de Lavera I, Álvarez-Córdoba M, Luzón-Hidalgo R, Suárez-Rivero JM, Tiscornia G, Oropesa-Ávila M. de la Mata M, et al. Diseases. 2016 Oct 11;4(4):31. doi: 10.3390/diseases4040031. Diseases. 2016. PMID: 28933411 Free PMC article. Review.

2

Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease.

Horowitz M, Braunstein H, Zimran A, Revel-Vilk S, Goker-Alpan O. Horowitz M, et al. Adv Drug Deliv Rev. 2022 Aug;187:114402. doi: 10.1016/j.addr.2022.114402. Epub 2022 Jun 25. Adv Drug Deliv Rev. 2022. PMID: 35764179 Review.

3

Novel beta-glucocerebrosidase chaperone compounds identified from cell-based screening reduce pathologically accumulated glucosylsphingosine in iPS-derived neuronal cells.

Naito Y, Sakamoto S, Kojima T, Homma M, Tanaka M, Matsui H. Naito Y, et al. SLAS Discov. 2023 Jun 25:S2472-5552(23)00048-5. doi: 10.1016/j.slasd.2023.06.002. Online ahead of print. SLAS Discov. 2023. PMID: 37369311 Free article.

4

The relationship between glucocerebrosidase mutations and Parkinson disease.

Migdalska-Richards A, Schapira AH. Migdalska-Richards A, et al. J Neurochem. 2016 Oct;139 Suppl 1(Suppl Suppl 1):77-90. doi: 10.1111/jnc.13385. Epub 2016 Feb 10. J Neurochem. 2016. PMID: 26860875 Free PMC article. Review.

5

Neuronopathic Gaucher disease: Beyond lysosomal dysfunction.

Arévalo NB, Lamaizon CM, Cavieres VA, Burgos PV, Álvarez AR, Yañez MJ, Zanlungo S. Arévalo NB, et al. Front Mol Neurosci. 2022 Aug 3;15:934820. doi: 10.3389/fnmol.2022.934820. eCollection 2022. Front Mol Neurosci. 2022. PMID: 35992201 Free PMC article. Review.

6

Elevated glucosylsphingosine in Gaucher disease induced pluripotent stem cell neurons deregulates lysosomal compartment through mammalian target of rapamycin complex 1.

Srikanth MP, Jones JW, Kane M, Awad O, Park TS, Zambidis ET, Feldman RA. Srikanth MP, et al. Stem Cells Transl Med. 2021 Jul;10(7):1081-1094. doi: 10.1002/sctm.20-0386. Epub 2021 Mar 3. Stem Cells Transl Med. 2021. PMID: 33656802 Free PMC article.

7

Coenzyme Q₁₀ partially restores pathological alterations in a macrophage model of Gaucher disease.

de la Mata M, Cotán D, Oropesa-Ávila M, Villanueva-Paz M, de Lavera I, Álvarez-Córdoba M, Luzón-Hidalgo R, Suárez-Rivero JM, Tiscornia G, Sánchez-Alcázar JA. de la Mata M, et al. Orphanet J Rare Dis. 2017 Feb 6;12(1):23. doi: 10.1186/s13023-017-0574-8. Orphanet J Rare Dis. 2017. PMID: 28166796 Free PMC article.

8

Autophagy and Lysosome Storage Disorders.

Ren H, Wang G. Ren H, et al. Adv Exp Med Biol. 2020;1207:87-102. doi: 10.1007/978-981-15-4272-5_5. Adv Exp Med Biol. 2020. PMID: 32671740 Review.

9

Cellular and biochemical response to chaperone versus substrate reduction therapies in neuropathic Gaucher disease.

Ivanova MM, Dao J, Kasaci N, Adewale B, Nazari S, Noll L, Fikry J, Sanati AH, Goker-Alpan O. Ivanova MM, et al. PLoS One. 2021 Oct 25;16(10):e0247211. doi: 10.1371/journal.pone.0247211. eCollection 2021. PLoS One. 2021. PMID: 34695170 Free PMC article.

10

Patients with Gaucher disease display systemic oxidative stress dependent on therapy status.

Kartha RV, Terluk MR, Brown R, Travis A, Mishra UR, Rudser K, Lau H, Jarnes JR, Cloyd JC, Weinreb NJ. Kartha RV, et al. Mol Genet Metab Rep. 2020 Dec 9;25:100667. doi: 10.1016/j.ymgmr.2020.100667. eCollection 2020 Dec. Mol Genet Metab Rep. 2020. PMID: 33335836 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year